Effective synthesis of benzodiazepine sulfonamide-based MGAT2 inhibitors and evaluation of their antitumor activity
Open Access
- 30 June 2025
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (28) , 23003-23006
Abstract
This study synthesized benzodiazepine sulfonamide-based MGAT2 inhibitors to combat cancer recurrence and resistance. Despite modest effects, compounds 13 and 16 showed enhanced antitumor activity. The six-step synthesis method using amino acids is industrially viable, offering a basis for future drug development.Keywords
Funding Information
- Chengde Medical University (202301)
- Natural Science Foundation of Hebei Province (H2023406003)
This publication has 28 references indexed in Scilit:
- Exploring the relationship between MGAT2 and glioblastoma: A Mendelian Randomization and bioinformatics approachBrain Research, 2025
- Monoacylglycerol acyltransferase-2 inhibits colorectal carcinogenesis in APCmin+/− miceiScience, 2024
- Discovery of novel pyridinones as MGAT2 inhibitors for the treatment of metabolic disordersBioorganic & Medicinal Chemistry Letters, 2023
- MGAT2 inhibitor decreases liver fibrosis and inflammation in murine NASH models and reduces body weight in human adults with obesityCell Metabolism, 2022
- Assessment of elementary derivatives of 1,5-benzodiazepine as anticancer agents with synergy potentialBioorganic Chemistry, 2021
- Novel fused 1,2,3-triazolo-benzodiazepine derivatives as potent anticonvulsant agents: design, synthesis, in vivo, and in silico evaluationsMolecular Diversity, 2019
- Identification and design of a novel series of MGAT2 inhibitorsBioorganic & Medicinal Chemistry Letters, 2013
- Novel 4-(4-substituted-thiazol-2-ylamino)-N-(pyridin-2-yl)-benzenesulfonamides as cytotoxic and radiosensitizing agentsArchives of Pharmacal Research, 2012
- Anticancer and radio-sensitizing evaluation of some new thiazolopyrane and thiazolopyranopyrimidine derivatives bearing a sulfonamide moietyEuropean Journal of Medicinal Chemistry, 2011
- Carbonic anhydrase inhibitors: E7070, a sulfonamide anticancer agent, potently inhibits cytosolic isozymes I and II, and transmembrane, tumor-associated isozyme IXBioorganic & Medicinal Chemistry Letters, 2004